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I ntroduction
Th e dynamic interaction between the heart and the 
systemic circulation allows the cardiovascular system to 
be eﬃ  cient in providing adequate cardiac output and 
arterial pressures necessary for suﬃ  cient organ perfusion 
[1]. Th e  cardiovascular system provides adequate pressure 
and ﬂ ow to the peripheral organs in diﬀ erent physio-
logical (rest and exercise) and pathological conditions 
because of the continuous modulation of the arterial 
system compliance, stiﬀ ness and resistance with respect 
to left ventricular (LV) systolic performance [2]. Card iac 
output is the ﬁ nal result of this dynamic modulation. 
Because LV stroke volume depends on myocardial 
contractility and loading conditions (preload and after-
load), both cardiac and arterial dysfunction can lead to 
acute hemodynamic decompensation and shock. Accord-
ing to the underlying pathophysiological mechanisms, 
altered hemodynamic proﬁ les can be classiﬁ ed as 
primarily reﬂ ecting cardiogenic, hypovolemic, obstruc-
tive or distributive shock.
Low cardiac output resulting in systemic hypoperfusion 
requires prompt and adequate treatment to restore 
cardio vascular function and prevent organ hypo per-
fusion. Current clinical guidelines recommend resusci-
tation with intravascular ﬂ uid infusions supplemented 
with selective use of inotropes and vasopressors to 
reverse shock in critically ill patients [3,4].  Howe ver, the 
treatment of acute he modynamic impairment should be 
tailored based on the etiological mechanism of the 
cardiovascular dysfunction. Herein lies a major problem 
with present guidelines: Th ey cannot distinguish the 
underlying causes of impaired LV stroke volume leading 
to impaired cardiac output.
Ventriculo-arterial coupling
Th e concept that the cardiovascular system works better
when the heart and the ar terial system are coupled has
been well demonstrated [5,6]. When t he h eart pumps
blood into the vascular tree at a rate and volume that
matches the capability of the arterial system to receive it,
both cardiovascular performance and its associated car-
diac energetics are optimal [7,8]. A cont ract ility or arterial
tone that is too high or too low decouples these processes
and can lead to cardiac failure independent of myocardial
ischemia or the toxic eﬀ ects of sepsis and related systemic
disease processes. Th is optimization means that the LV
workload and the arterial system optimally match when
the left ventricle ejects the blood into the arterial system
and is quantiﬁ ed by ventriculo-arterial (V-A) coupling
analysis. Th is process is optimized without excessive
changes in LV pressure, and the mechanical energy of LV
ejection is completely transferred from the ventricle to
the arterial system [9,10]. Th e ro le o f V-A coupling in the
management of critically ill patients with severe he-
modynamic instability and shock is becoming in-
creasingly clear.
V-A coupling can be deﬁ ned as the ratio of the arterial 
elastance (Ea) to the ventricular elastance (Ees). Th is ratio
was ﬁ rst proposed by Suga [11] as a method t o evaluate 
the mechanical eﬃ  ciency of the cardiovascular system 
and the interaction between cardiac performance and 
vascular function. Th e Ea/Ees ratio has been consistently 
demonstrated to be a reliable and eﬀ ective measure of 
cardiovascular performance [9,11,12]. Bur khoﬀ  and 
Sagawa, and successively many other investigators, have 
demonstrated that when the Ea/Es is near unity, the 
eﬃ  ciency of the system is optimal. In this case, the left 
ventricle provides an adequate stroke volume with the
lowest possible energetic consumption [13,14]. Th us, V -A 
co upling is an eﬀ ective index of the mechanical perfor-
mance of the left ventricle and of the dynamic modulation 
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of the cardiovascular system. In addition, the Ea/Ees 
reﬂ ects cardiac energetics. Th e balance between myo-
cardial oxygen consumption and the mechanical energy 
required to perform this work appears to be optimal 
when the heart and the peripheral vascular system are 
coupled.
Th e area of the LV pressure-volume (P-V) loop (Fig. 1) 
during a single  cardiac cycle represents the total mecha-
nical energy of the heart during that beat and has a linear 
correlation with myocardial oxygen consumption [15]. 
Th e energetic  eﬃ   ciency of the cardiovascular system is 
optimal when all the pulsating energy of the heart is 
transmitted to the arterial system [12]. Eﬀ ective unde r-
standing of V-A coupling requires an appropriate under-
standing of the concepts of the determinants, Ea and Ees. 
And the eﬀ ective use of these concepts requires an under-
standing as to how they may be derived at the bedside in 
critically ill patients.
Left ventricular elastance (E es)
When the left ventricle ejects, arterial pressure increases 
and the LV stroke volume is transferred into the aorta. As 
LV volume decreases to its end-systolic minimum, the 
actual end-systolic volume (ESV) is a function of not only 
intrinsic cardiac contractility, but also arterial pressure. 
For the same LV end-diastolic volume (EDV) and intrinsic 
cardiac contractility, if arterial pressure at end-systole 
were less, then LVESV would also be lower and LV stroke 
volume greater. Similarly, increasing arterial pressure has 
the opposite eﬀ ect to increasing LVESV and decreasing 
stroke volume. Importantly, the resultant potential end-
systolic pressure-volume points possible as arterial 
pressure is independently varied describe a tight linear 
relationship called the end-systolic pressure-volume 
relationship (ESPVR). Th e slope of the ESPVR is the LV 
elastance (Ees) (Fig. 1) and is determined for the  intrinsic 
contractility of the heart. Th e steeper the slope, the 
greater the contractility [16]. Ees (mm Hg/ml) is a usef ul, 
load independent index of myocardial contractility and 
LV inotropic eﬃ  ciency (end-systolic LV stiﬀ ness) [17]. 
Although myocardial cont ractility is the main deter mi-
nant of LV systolic function, biochemical properties of 
the LV myocytes (stiﬀ ness, compliance, ﬁ brosis, etc.), 
cardiac myocyte contraction synchrony and geometric 
remodeling of the LV cham ber can also signiﬁ cantly 
inﬂ uence LV performance [18]. Th erefore, Ees should be 
considered as an integrated measure of LV systolic per-
formance derived from the complex association between 
the inotropic eﬃ  ciency and the functional, structural and 
geometric characteristics of the left ventricle [19].
Arterial elastance (Ea)
Ea (mm  Hg/ml) is the expression of the total afterload 
imposed on the left ventricle and represents the complex 
association of diﬀ erent arterial properties including wall 
stiﬀ ness, compliance and outﬂ ow resistance. Th us, the 
total arterial compliance, impedance and the systolic and 
diastolic time interval are signiﬁ cant components of the 
arterial load [11]. Graphically, Ea can be describ ed as the 
slope of the line running from the LVEDV to the LV end-
systolic pressure (ESP) on the P-V loop (Fig.  1). Oper-
ation ally, Ea can be deﬁ ned as the capability of the arterial 
vessels to increase pressure when LV stroke volume 
increases.
A-V coupling measurement
According t o the seminal studies of Frank and Starling, 
Grossman and colleagues, and subsequently other investi-
gators, LV contractile function can be evaluated by the 
relationship between the ESP and the ESV [20,21]. After 
the experimental inve stiga tions of Suga and Sugawa on 
isolated canine hearts, the assessment of V-A coupling in 
humans has been less successful because of the invasive 
techniques needed to acquire these measures. Because of 
the recognized importance of V-A coupling in the 
management of critically ill patients, much eﬀ ort has 
been put into achieving non-invasive measurement 
approaches [22]. Despite several proposed non-invas ive 
approaches to evaluate Ea/Ees, only the modiﬁ ed single 
beat method developed by Chen et al. has been validated 
against the invasive measurement of Ees [23]. Th e single 
beat method is based on the assumption that because the 
time-variation of LV elastance is not inﬂ uenced by 
loading conditions or heart rate (HR), the evaluation of 
the P-V loop can be obtained by a single heart beat [24]. 
Th e non-invasive method developed b y Chen et  al. 
Figure 1. The left ventricular (LV) P-V loop. The P-V loop area 
is highlighted in blue. The slopes of LV elastance (Ees) and arterial 
elastance (Ea) are shown. ESV: end-systolic volume; ESP: end-systolic 
pressure; EDV: end-diastolic volume; EDP: end-systolic pressure.
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utilizes echocardiographic measures of LV end-diastolic 
and end-systolic areas. Chen et al. demonstrated that this 
method could be used for obtaining the single-beat 
measure of Ees (Ees[SB]), through the measure of LV 
ejection fraction (LVEF), stroke volume, pre-ejection 
time and systolic time interval (Fig. 2) when coupled with 
systolic and diasto lic arterial pressure measurements 
[23].
Ea is calculated as ESP/stroke volume. From the re-
arrange ment of this equation, Ea is proportional to the 
sum of HR, arterial resistance and [(ESP – mean arterial 
pressure[MAP])/stroke volume]. Since end-systolic 
arterial pressure occurs slightly after peak systolic pressure 
is achieved, Ea can be calculated as 0.9 × systolic arterial 
pressure/stroke volume , where 0.9  × systolic arterial 
pressure equals LVESP [23,25].
Since all these measures can be read ily m ade at the 
bedside, it is possible to assess V-A coupling in critically 
ill patients.
Ventriculo-arterial decoupling in altered 
hemod ynamic states
Although the occurrence of V-A decoupling is generally 
associated with pathological states, in some physiological 
conditions, such as during exercise or with increased age, 
a mismatch between LV performance and arterial system 
function can occur.
According to the physiological changes occurring 
during exercise, the cardiovascular system modulates its 
performance to provide adequate pressure and ﬂ ow to 
peripheral organs in the presence of increased metabolic 
demand. Because the Ea/Ees is normally coupled in 
healthy humans at rest, during exercise Ees increases 
more than Ea; consequently, the ratio of Ea to Ees 
decreases [26]. Because LV performance and, therefore, 
Ees  normally increases during exercise, Ea can increase, 
decrease or be unchanged. Th e Ea modiﬁ cations impact 
Ea/Ees in conditions of increased LV work. Ea generally 
increases in elderly people as a consequence of the 
structural changes in the arterial properties (compliance, 
stiﬀ ness, pulse wave). Th e mismatch between Ea and Ees 
during exercise can be blunted in elderly people because 
of a reduction in the cardiovascular reserve. Furthermore, 
cardiovascular diseases (hypertension, coronary artery 
disease, diabetes mellitus), which have an impact on V-A 
coupling, frequently occur in elderly patients.
Cardiovascular impairment leading to acute systemic 
hypotension and shock can occur in many diﬀ erent 
clinical scenarios. Cardiovascular dysfunction is generally 
characterized by an altered Ea/Ees due to either the 
decrease in Ees or to the signiﬁ cant increase in Ea. 
Operationally, the system becomes uncoupled when the 
ratio of arterial to ventricular elastance is > 1 (Ea/Ees > 1), 
while an Ea increase is the consequence of an increase of 
the arterial load.
Ventriculo-arterial decoupling due to decreased Ees
According to the hemodynamic proﬁ le of the underlying 
pathology, an Ees decrease indicates an impairment in 
myocardial contractility, resulting in reduction of LV 
performance. Although myocardial ischemia and acute 
myocardial infarction are the most common causes of 
Figure 2. Echocardiographic measurements of left ventricular (LV) time intervals (left) and LV ejection fraction (EF, right). The white arrow 
indicates the beginning of the QRS complex, the dark blue arrows indicate the aortic valve opening and closure. The light blue lines show the time 
interval measurements.
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LV contractile dysfunction, other pathologies, such as 
myocarditis and severe cardiomyopathy (dilative and 
hyper trophic), can be characterized by myocardial de-
pres sion and diminished Ees [27,28]. Th e acute decom-
pensation of LV function c an le ad to severe hemo-
dynamic impairment and shock.
Acute heart failure
Acute failure of LV systolic fu nction is characterized by 
the inability of the heart to provide an adequate stroke 
volume to match the metabolic demands of the body. 
Acute systolic cardiac dysfunction results in both a low 
ejection fraction and increased ﬁ lling pressures in the 
attempt to maintain a suﬃ  cient stroke volume. For this 
reason, the LV ESPVR is shifted downward and right-
ward, and Ees decreases. At the same time, Ea signiﬁ -
cantly increases because of increased sympathetic tone as 
the normal response of the autonomic nervous system to 
compensate for the reduced LV stroke volume. Th us, one 
sees tachycardia and increased arterial tone [2]. Hence, 
the cardiovascular system is generally u ncoupled in acute 
heart failure, and Ea/Ees increases up to three or four 
fold [29]. Th erefore, the treatment of acute heart failur e is 
usually to decrease Ea by calcium channel blockers, beta-
blockers and other vasodilating agents, whereas Ees is 
increased by inotrope infusions. Traditionally, the 
management of acute heart failure is based on inotropic 
agents aimed to improve myocardial contractility and to 
restore organ perfusion [30]. Th e inotropic agents 
commonly employed in the  treatment of acute heart 
failure (catecholamines and phosphodiesterase III inhibi-
tors) induce well-described adverse eﬀ ects, such as 
increased myocardial oxygen consumption, ar rhythmias 
and increased mortality [12]. In recent years, the thera-
peutic use of the no vel calcium sensitizer, levosimendan, 
has been progressively emphasized because of its 
inotropic and vasodilator properties [31,32]. Because of 
its intrinsic performance, lev osime ndan impacts both Ea 
and Ees and improves V-A coupling [12]. Moderate 
systemic arterial hypotension can be i nduced by 
levosimendan, which then requires the administration of 
low doses of norepinephrine. Th e association between 
the inotropic and vasopressor action seems to improve 
cardiovascular performance by matching Ea and Ees.
Cardiac surgery
Cardiogenic shock is the most severe clinical manifes-
tation of perioperative acute heart failure after cardiac 
surgery and leads to systemic hypoperfusion and organ 
dysfunction that generally requires either pharmaco logical 
or mechanical support. Th e acute reduction in Ees, from 
many diﬀ erent causes that range from inadequate 
myocardial protection to myocardial stun ning, is usually 
the main reason for the uncoupled Ea/Ees ratio.
Treatment with inodilator drugs in post-cardiotomy 
acute heart failure has been demonstrated to be eﬀ ective 
in restoring V-A coupling and improving LV performance 
[33,34].
Tachycardia
Tachycardia induced by stress conditions and  during 
exercise is generally well tolerated by healthy people. 
Indeed, the increase in HR is a compensatory mechanism 
that enhances myocardial contractility and LV perfor-
mance [2]. Th is force-frequency relationship has bene-
ﬁ cial eﬀ ects on cardiac performance, which contribute to 
maintain the eﬃ  ciency of the cardiovascular system and 
provide optimal V-A coupling. Th e intrinsic mechanism 
underlying the force-frequency relationship is most likely 
the dynamic balance of the intracellular Ca2+ concentra-
tion [35]. In acute heart failure patients, baseline LV V-A 
un coupling can be signiﬁ cantly worsened by tachycardia 
because the normal force-frequency relationship is 
impaired.
Acute systemic hypotension
Several diﬀ erent etiological mechanis ms can cause 
hypotension, but systemic arterial hypotension is 
generally the ﬁ rst and often life-threatening symptom of 
acute cardiovascular dysfunction. Either heart failure or 
circulatory impairment can lead to systemic arterial 
hypotension and hemodynamic decompensation. Because 
peripheral organ perfusion strictly depends on the MAP, 
systemic arterial hypotension should be promptly 
reversed. According to recommended treatments, ﬂ uid 
resuscitation is generally the ﬁ rst therapeutic approach 
[3,4]. Indeed, the hemodynamic response to ﬂ uid 
administration  depe nds on either the increase in stroke 
volume consequent to ﬂ uid resuscitation or on other 
factors, including arterial tone [1,36]. MAP is the product 
of the interaction between LV stroke  volu me and arterial 
system function expressed by the Ea. Recently, we pro-
posed a bedside method to evaluate the dynamic arterial 
elastance (Eadyn) to determine which patients are 
responders to ﬂ uid resuscitation [37]. In mechanically 
ventilated patients, Eadyn corresponds to th e ratio of 
pulse pressure variation (PPV) to stroke volume variation 
(SVV) during a single positive pressure breath. Th e 
bedside evaluation of the Eadyn should allow either 
functional assessment of arterial tone or of ﬂ uid res-
ponsive ness in severely hypotensive patients. Further 
investigations are required because of both the limita-
tions of the published studies and the small populations 
enrolled, but the predictive value of Eadyn suggests a 
useful application in clinical practice.
Although MAP is the main determinant of organ 
perfusion, it can also be in ﬂ uenced by ﬂ ow distribution 
and tissue oxygenation. Despite the restoration of a 
Guarracino et al. Critical Care 2013, 17:213 
http://ccforum.com/content/17/2/213
Page 4 of 7
normal MAP, patients with cardiovascular dysfunction 
can suﬀ er from decreased organ oxygenation and 
perfusion [38]. In this context, a suﬃ  cient MAP should 
be maintained in he modynamically instable patients to 
prevent any further tissue in jury [3].
 Ventriculo-arterial decoupling due to increased Ea
Acute systemic hypertension
Increased arterial pressure represents the most common 
cause of pressure overload of the left ventricle and plays a 
key role in the evolution of ventricular hypertrophy, 
dysfunction and failure. Hypertensive crisis is charac ter-
ized by a sudden increase in blood pressure associated 
with or followed by signs of impairment in target organs, 
such as heart, kidney and brain. Most patients arriving at 
the emergency department with elevated blood pressure 
and acute pulmonary edema have a normal LVEF, 
suggesting that acute heart failure in these situations is 
due to diastolic dysfunction [39]. However, LV systolic 
dysfunction has also been reported in association with 
un controlled systemic hypertension, which may be res-
ponsible for the development of acute heart failure and 
pulmonary edema [40]. In these situations, the acute LV 
decompensation dramatically improves with rapid blood 
pressure normalization.
Th e mechanism by which a hypertensive crisis may 
cause acute and severe LV systolic dysfunction, even 
causing acute pulmonary edema, consists of acute V-A 
uncoupling because of an abrupt and exaggerated 
increase in Ea. Such afterload mismatch leads to an 
exhaustion of the preload reserve of the left ventricle 
[40]. Th e rapid reduction in elevated blood pressure by 
aggressive treatment usually induces a regression of myo-
cardial dysfunction by restoring Ea and, therefore, a 
coupling of the Ea/Ees ratio. Th us, consideration of the 
pathophysiological role of V-A decoupling allows the true 
pathogenic mechanism of acute heart failure in a patient 
with normal LV systolic function to be determined.
Ventriculo-arterial decoupling in septic shock
Th e hemodynamic proﬁ le of s eptic shock is primarily 
characterized by generalized vasodilatation resulting in 
severe hypotension with systemic hypoperfusion [41]. 
Th e occurrence of myocardial depression and eventual 
cardiac dysfuncti on has been largely recognized in patients 
with septic shock, although the pathogenetic mechanisms 
of the myocardial injury are not yet completely under-
stood [42,43].
In most of the patients with septic shock, cardio-
vascular eﬃ  cie ncy i s impaired, and the Ea/Ees becomes 
uncoupled (Ea/Ees  >  1). Th e hemodynamic proﬁ le is 
characterized by both the signiﬁ cant increase in Ea and 
the decrease in Ees. Because the increase in Ea is 
generally induced by pharmacological vasoconstriction 
(norepinephrine) and the consequent increase in arterial 
tone, a decrease in Ees generally depends on the reduc-
tion in myocardial contractility. Whatever the underlying 
mechanism, when A-V uncoupling occurs in septic shock, 
the cardiac energetics are unfavorable and are often 
sacriﬁ ced to maintain tissue perfusion. Despite the severe 
hemodynamic dysfunction, Ea/Ees can be normally 
coupled in patients with septic shock (Ea/Ees  =  1). In 
these cases, the proper interaction between LV perfor-
mance and arterial system function can depend on both a 
normal cardiac function and on a proper therapeutic 
approach with ﬂ uid administration, inotropes and 
vasoconstrictors.
According to international guidelines, management of 
septic shock requires either ﬂ uid resuscitation or the 
employment of vasopressors (norepinephrine) to 
maintain an adequate cardiac output and tissue perfusion 
[4]. Th e use of inotropes is recommended when cardiac 
dysfunction and an increase in ﬁ lling pressures occur. 
Recently, the use of levosimendan has been suggested for 
the treatment of myocardial dysfunction associated with 
septic shock [44,45].
Right ventricular dysfunction and V-A coupling
Th e cardiovascular system can  be acu tely decompensated 
by right ventricular (RV) failure with consequent severe 
hemodynamic instability and systemic hypoperfusion 
[46]. Th e RV dysfunction can be due to intrinsic mecha-
nisms that occur in myocardial  infarction or can be 
secondary to an increase in the RV afterload caused by 
pulmonary hypertension. Despite the underlying etiolo-
gical mechanisms, RV uncoupling can occur [47].
Because the right ventricle contributes to the eﬃ  ciency 
of the cardiovascular system through right V-A coupling, 
the assessment of the Ea/Ees of the right side of the 
circulation can play a role in the management of critically 
ill patients [48]. RV V-A coupling expresses the optimal 
interaction between RV performance and fun ction of the 
pulmonary vascular system. When Ees decreases (RV 
acute myocardial infarction, septic shock) or Ea increases 
(pulmonary hypertension, acute respiratory distress 
syndrome [ARDS]), the right side of the cardiovascular 
apparatus becomes uncoupled.
Although evaluation of RV elastance requires invasive 
techniques with signiﬁ cant limitations for clinical practice, 
non-invasive models to assess the RV Ea/Ees have 
recently been proposed. Pulmonary artery catheteri-
zation and cardiac magnetic resonance may be useful in 
determining RV V-A coupling [48,49].
Conclusion
Although the management of shock patients has 
traditionally been  based on ad vanced hemodynamic 
monitoring, the role of echocardiography in the 
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evalu a tion of patients with acute hemodynamic de-
compen sation has been progressively expanding in the 
last decades.
Th e management of critically ill patients with acutely 
altered hemodynamic states can beneﬁ t from the assess-
ment of V-A coupling. Since the introduction of echo-
cardiographic methods to assess cardiovascular function, 
the bedside evaluation of the Ea/Ees has become available 
and reliable.
Th e diagnostic function of echocardiographic assess-
ment is enhanced by its capability to contribute to an 
evaluation of the Ea/Ees ratio and, therefore, V-A coup-
ling in patients with acute hemodynamic impairment. 
Th e assessment of cardiovascular function by evaluation 
of the Ea/Ees ratio can oﬀ er an adjunctive perspective for 
understanding the pathophysiology of altered hemo-
dynamic proﬁ les, and for guiding therapeutic strategies 
and testing the eﬀ ectiveness of treatments. However, this 
concept still needs to be tested in large trials.
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